SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001640334-23-001135
Filing Date
2023-06-27
Accepted
2023-06-27 17:14:46
Documents
1
Period of Report
2023-06-27

Document Format Files

Seq Description Document Type Size
1 FORM 6-K nymox_6k.htm 6-K 8738
  Complete submission text file 0001640334-23-001135.txt   9783
Mailing Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2
Business Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2 1-800-936-9669
NYMOX PHARMACEUTICAL CORP (Filer) CIK: 0001018735 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-12033 | Film No.: 231048442
SIC: 2835 In Vitro & In Vivo Diagnostic Substances